Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.

Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.